In early 2024, Apple discontinued the blood oxygen monitoring feature on the Apple Watch due to a patent dispute with Masimo, a medical technology company. The legal battle remains unresolved, with neither party showing signs of concession. Blood oxygen monitoring, commonly referred to as pulse oximetry, is a non-invasive technique for measuring blood oxygen saturation (SpO2), a feature that has been integrated into Apple Watches since the Series 6.